Live Cell Imaging Market

Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services) Application (Cell Biology, Drug Discovery) Technology (Time-lapse Microscopy, FRET) End User (Contract Research Organization, Research Institutes) - Global Forecast to 2025

Report Code: BT 3390 Oct, 2020, by marketsandmarkets.com

[ 212 Pages Report] The global live cell imaging market size is expected to reach USD 2.8 billion by 2025 from an estimated value of USD 1.8 billion in 2020, growing at a CAGR of 8.8% during the forecast period. growing adoption of high-content screening techniques in drug discovery and rising incidence of cancer primarily drives the market for live cell imaging. The growth in research funding and rising government funding and investment in regenerative medicine research will also support the market growth in the coming years. However, the high cost of high-content screening systems is limiting the overall adoption of these products.

Attractive Opportunities In The Live Cell Imaging Market

To know about the assumptions considered for the study, Request for Free Sample Report

Covid-19 Impact on the Live Cell Imaging Market

The COVID-19 pandemic has resulted in a tremendous increase in the burden on healthcare organizations across the globe. According to the WHO, as of September 29, 2020, there were 33,249,563 confirmed cases of COVID-19, including 1,000,040 deaths, with the highest number of deaths in the Americas, followed by Europe and Southeast Asia. Furthermore, due to the COVID-19 pandemic, governments across the globe have announced country-wide lockdowns as well as social distancing measures to prevent the collapse of their health systems. Shutdown measures to curb COVID-19, however, resulted in a decrease in the number of orders of biological microscopes during the three months of April–June 2020. This has further negatively impacted the quarterly revenue of leading players operating in this market. 

Currently, no effective treatment for COVID-19 is available in the form of vaccines or antiviral drugs, and patients are currently treated symptomatically. According to the WHO, there are 70 vaccine candidates under development, and three candidates are already being tested in human trials. At the forefront of the COVID-19 outbreak, many researchers worldwide are engaged in the viral research of SARS-CoV-2, the virus that causes COVID-19. Live cell imaging systems, including advanced microscopy systems, help researchers investigate cellular behavior during viral research. Biomedical research requires the analysis of enormous amounts of data to develop vaccines. Therefore, major live cell imaging system providers, such as Leica Microsystems (Germany) and CytoSMART Technologies (Netherlands), have donated live cell imaging systems to assist COVID-19 researchers. 

The normalization of the global economy will slowly increase the demand for live cell imaging systems in non-COVID-related research activity labs, leading to market growth from the first quarter of 2021. Furthermore, players operating in the market are altering their strategies, for both long-term and short-term growth, by tapping the research market and developing innovative products to combat the pandemic. On the other hand, even though the impact of COVID-19 on the live cell imaging market is low compared to other medical device markets, timely development and implementation of contingency plans are critical for business operations and, in particular, for key imported raw materials. 

Live Cell Imaging Market Dynamics 

Driver: Growing adoption of high-content screening techniques in drug discovery

The traditional method of toxicity and drug safety studies involves the screening of large libraries through high-throughput screening. This method is expensive, has a low success rate, and is resource- and time-consuming. To overcome these challenges, pharmaceutical companies are increasingly adopting high-content screening (HCS) cell-based assays for identifying the effects of toxicity in drug development studies (cell-based imaging enables the monitoring of drug toxicity mechanisms, such as oxidative stress, micronuclei, mitochondrial dysfunction, steatosis, and apoptosis). The use of HCS makes the drug development process more time- and cost-efficient. Owing to these factors, the adoption of high-content screening for toxicity studies is expected to increase during the forecast period. This, in turn, is expected to drive market growth as live cell imaging is used in HCS to identify meaningful information from complex systems such as in vitro, in vivo, and ex vivo systems. 

Restraints: High cost of high-content screening systems

High-content screening (HCS) instruments are equipped with advanced features and functionalities and are, therefore, priced at a premium. A confocal microscope, for instance, can cost more than USD 250,000, and a wide-field microscope can cost more than USD 100,000. Similarly, the InCell 2000 Analyzer system (from GE Healthcare) used in HCS costs around USD 240,000. Academic research laboratories find it difficult to afford such high-priced instruments as they have restricted budgets. The high price of these instruments is also a concern for several pharmaceutical companies as they require multiple HCS systems in their R&D activities (thus increasing the total cost spent on these systems). In addition to the high procurement costs, the maintenance costs and several other indirect expenses increase the total cost of ownership of these instruments. This is one of the major factors limiting the adoption of live cell imaging instruments in clinical and research applications, especially in emerging countries. 

Opportunities: Untapped potential of emerging markets

Emerging markets such as Brazil, Russia, India, and China are expected to offer significant opportunities for the growth of the live cell imaging market. This can primarily be attributed to the growing R&D funding for various research organizations in these countries. Currently, China accounts for about 20% of the global R&D spending and is the second-largest investor in R&D, globally, after the US. The country is projected to overtake the US in R&D spending by 2023 (Source: Council on Foreign Relations). Cost savings and a lack of regulations are among the most important drivers boosting preclinical activities in China. The growing funding and investments in life science research, availability of highly skilled personnel, and a favorable regulatory environment are the other major factors supporting this trend. Moreover, currently, China has many CROs that provide preclinical and clinical research services to multinational pharmaceutical companies. The growth of preclinical/clinical research in China is expected to augment the demand for live cell imaging in the country in the coming years. 

Challenges: Maintaining cell viability and the cellular environment in cell cultures

Running live cell imaging experiments successfully can be a major challenge. The conditions under which cells are maintained under microscopes decide the success or failure of the experiment. Therefore, maintaining living cells on slides is the most crucial part of the experiment. The cells used in experiments should be in good condition and function normally under a microscope in the presence of synthetic fluorophores or fluorescent proteins. Additionally, maintaining a constant cellular environment is very important during the experiment; the cells should be grown in culture media in a carbon dioxide incubator. Temperature also plays a crucial role in maintaining cell viability in a culture. Hence, as the cell viability and cellular environment are dependent on several specific requirements, the chances of a live cell imaging experiment being unsuccessful are high. 

Global Live Cell Imaging Market Interconnections 

Global Live Cell Imaging Market Interconnections

To know about the assumptions considered for the study, download the pdf brochure

The consumables segment is projected to grow at the highest CAGR during the forecast period

Based on product & service, the global live cell imaging market is segmented into instruments, consumables, software, and services. The consumables segment, on the other hand, is expected to grow at the highest CAGR during the forecast period. The need for the frequent purchase of consumables is expected to play a key role in the growth of the consumables market during the forecast period. 

The pharmaceutical & biotechnology companies segment accounted for the largest share of the live cell imaging market in the year 2019.

Based on end user, the live cell imaging market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and contract research organizations (CROs). In 2019, pharmaceutical & biotechnology companies segment accounted for the largest share of the live cell imaging market. The large share of this segment can be attributed to the increasing R&D activities and the patent cliff of various blockbuster drugs. 

The Asia Pacific region is expected to show the highest growth rate during the forecast period.

Geographically, the global live cell imaging market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific is expected to show the highest growth rate during the forecast period. The high growth rate of this region can mainly be attributed to the factors such as the government initiatives for research on stem cell therapy, the rising prominence of regenerative medicine research, growth of preclinical/clinical research in China, favorable changes in foreign direct investment (FDI) regulations in the pharmaceutical industry in India, and growth of the pharmaceutical and biopharmaceutical sectors in South Korea. 

Live Cell Imaging Market By Region

Key Market Players

The leading players in this market include Danaher Corporation (US), Carl Zeiss AG (Germany), Nikon Corporation (Japan), Olympus Corporation (Japan), PerkinElmer, Inc. (US), GE Healthcare (US), Bruker Corporation (US), Thermo Fisher Scientific Inc. (US), Sartorius AG (Germany), Oxford Instruments (UK), BioTek Instruments (US), Etaluma, Inc. (US), CytoSMART Technologies (Netherlands), NanoEnTek Inc. (Korea), Phase Focus Limited (UK), Tomocube, Inc. (South Korea), Phase Holographic Imaging PHI AB (Sweden), BD Biosciences (US), Sony Biotechnology, Inc. (US), Merck KGaA (Germany), KEYENCE Corporation (Japan), ibidi GmbH (Germany), Bio-Rad Laboratories (US), Logos Biosystems (South Korea), and Nanolive SA (Switzerland).

 Scope of the Report: 

Report Metric

Details

Market size available for years

2018–2025

Base year considered

2019

Forecast period

2020–2025

Forecast units

Value (USD)

Segments covered

Product & Service, Application, Technology, End User, and Region

Geographies covered

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Companies covered

Danaher Corporation (US), Carl Zeiss AG (Germany), Nikon Corporation (Japan), Olympus Corporation (Japan), PerkinElmer, Inc. (US), GE Healthcare (US), Bruker Corporation (US), Thermo Fisher Scientific Inc. (US), Sartorius AG (Germany), Oxford Instruments (UK), BioTek Instruments (US), Etaluma, Inc. (US), CytoSMART Technologies (Netherlands), NanoEnTek Inc. (Korea), Phase Focus Limited (UK), Tomocube, Inc. (South Korea), Phase Holographic Imaging PHI AB (Sweden), BD Biosciences (US), Sony Biotechnology, Inc. (US), Merck KGaA (Germany), KEYENCE Corporation (Japan), ibidi GmbH (Germany), Bio-Rad Laboratories (US), Logos Biosystems (South Korea), and Nanolive SA (Switzerland).
Total 25 major players covered

The live cell imaging market research report categorizes the market into the following segments and subsegments: 

By Product  & Service

  • Instruments
  • Microscopes
  • Standalone Systems
  • Cell Analyzers
  • Accessories
  • Consumables
  • Reagents
  • Assay Kits
  • Media
  • Other Consumables
  • Software
  • Services 

By Application

  • Cell Biology
  • Stem Cells
  • Developmental Biology
  • Drug Discovery 

By Technology

  • Time-lapse Microscopy
  • Fluorescence Resonance Energy Transfer (FRET)
  • Fluorescence Recovery After Photobleaching (FRAP)
  • High-content Screening (HCS)
  • Other Technologies 

By End-User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs) 

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific (RoAPAC)
  • Latin America
  • Middle East & Africa 

Recent Developments 

  • In September 2020, CytoSMART Technologies (Netherlands) launched CytoSMART Multi Lux, a remote live cell imaging system.
  • In July 2020, Etaluma, Inc. (US) partnered with INNOMED GmbH (Germany) to introduce entry-level incubator cell imaging to the Americas. Through the partnership, Etaluma strengthened its Lumascope offerings.
  • In December 2019, Leica Microsystems (Germany) entered into agreement with European Molecular Biology Laboratory (EMBL) (Germany) to develop new imaging technologies applicable in life science.
  • In April 2019, Nikon Corporation (Japan) launched two new silicone immersion objective lenses—the CFI Plan Apochromat Lambda S 25XC Sil and the CFI Plan Apochromat Lambda S 40XC Sil—for confocal laser microscope systems and Ti2 inverted research microscopes.
  • In July 2018, Bruker Corporation (US) acquired JPK Instruments AG (Germany) to enhance its microscopy offerings. 

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 28)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 32)
    2.1 RESEARCH DATA
 FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
   FIGURE 2 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
       FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION
 FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
 FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (ILLUSTRATIVE EXAMPLE)
 FIGURE 6 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
 FIGURE 7 DATA TRIANGULATION METHODOLOGY
    2.4 ASSUMPTIONS FOR THE STUDY
    2.5 COVID-19 HEALTH ASSESSMENT
    2.6 COVID-19 ECONOMIC ASSESSMENT
    2.7 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
 FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY
 FIGURE 9 SCENARIOS OF RECOVERY FROM COVID-19 IN THE GLOBAL ECONOMY
    2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO OF THE LIVE CELL IMAGING MARKET
 
3 EXECUTIVE SUMMARY (Page No. - 44)
  TABLE 1 LIVE CELL IMAGING MARKET SNAPSHOT, 2020 VS. 2025
  FIGURE 10 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION)
  FIGURE 11 LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
  FIGURE 12 LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
  FIGURE 13 LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2020 VS. 2025 (USD MILLION)
  FIGURE 14 LIVE CELL IMAGING MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
  FIGURE 15 LIVE CELL IMAGING MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
  FIGURE 16 GEOGRAPHICAL SNAPSHOT OF THE LIVE CELL IMAGING MARKET

4 PREMIUM INSIGHTS (Page No. - 52)
    4.1 LIVE CELL IMAGING MARKET OVERVIEW
 FIGURE 17 GROWING ADOPTION OF HIGH-CONTENT SCREENING TECHNIQUES AND RISING INCIDENCE OF CANCER ARE KEY FACTORS DRIVING MARKET GROWTH
    4.2 APAC: LIVE CELL IMAGING MARKET, BY APPLICATION (2019)
 FIGURE 18 CELL BIOLOGY APPLICATIONS COMMANDED THE LARGEST SHARE OF THE APAC LIVE CELL IMAGING MARKET IN 2019
    4.3 LIVE CELL IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
 FIGURE 19 CHINA IS THE FASTEST-GROWING MARKET FOR LIVE CELL IMAGING
    4.4 REGIONAL MIX: LIVE CELL IMAGING MARKET
 FIGURE 20 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
    4.5 LIVE CELL IMAGING MARKET: DEVELOPED VS. DEVELOPING MARKETS
 FIGURE 21 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 57)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
 TABLE 2 MARKET DYNAMICS: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 Growing adoption of high-content screening techniques in drug discovery
                    5.2.1.2 Rising incidence of cancer
       FIGURE 22 GLOBAL CANCER INCIDENCE, 2008-2030
       TABLE 3 GLOBAL CANCER INCIDENCE, BY REGION/COUNTRY, 2018 VS. 2030
                    5.2.1.3 Growing availability of research funds
                    5.2.1.4 Rising government funding in regenerative medicine research
       TABLE 4 TOTAL FUNDING, BY SOURCE TYPE, 2016-2019 (USD MILLION)
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of high-content screening systems
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Emerging markets
                    5.2.3.2 Applications of HCS in personalized medicine
           5.2.4 CHALLENGES
                    5.2.4.1 Maintaining cell viability and the cellular environment in cell cultures
                    5.2.4.2 Dearth of skilled professionals
    5.3 COVID-19 IMPACT ON THE LIVE CELL IMAGING MARKET

6 INDUSTRY INSIGHTS (Page No. - 64)
    6.1 INTRODUCTION
    6.2 INDUSTRY TRENDS
           6.2.1 RISING FOCUS OF MARKET PLAYERS ON ADVANCED PRODUCT LAUNCHES
           6.2.2 GROWING ADOPTION OF LABEL-FREE TECHNOLOGIES
    6.3 SUPPLY CHAIN ANALYSIS
 FIGURE 23 SUPPLY CHAIN ANALYSIS: LIVE CELL IMAGING MARKET
    6.4 VALUE CHAIN ANALYSIS
 FIGURE 24 LIVE CELL IMAGING MARKET: VALUE CHAIN ANALYSIS

7 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE (Page No. - 68)
    7.1 INTRODUCTION
 TABLE 5 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    7.2 IMPACT OF COVID-19 ON THE LIVE CELL IMAGING PRODUCT & SERVICE MARKET
    7.3 INSTRUMENTS
 TABLE 6 LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
 TABLE 7 LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY,2018-2025 (USD MILLION)
           7.3.1 MICROSCOPES
                    7.3.1.1 Broad applications and emerging technologies have resulted in the growing demand for microscopes
       TABLE 8 CONVENTIONAL MICROSCOPES OFFERED BY KEY MARKET PLAYERS
       TABLE 9 CONFOCAL MICROSCOPES OFFERED BY KEY MARKET PLAYERS
       TABLE 10 FLUORESCENCE MICROSCOPES OFFERED BY KEY MARKET PLAYERS
       TABLE 11 LIVE CELL IMAGING MICROSCOPES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
       TABLE 12 LIVE CELL IMAGING MICROSCOPES MARKET, BY REGION, 2018-2025 (UNITS)
           7.3.2 STANDALONE SYSTEMS
                    7.3.2.1 Standalone systems provide in-depth image analysis of live cells at a faster rate-a key factor driving market growth
       TABLE 13 STANDALONE SYSTEMS OFFERED BY KEY MARKET PLAYERS
       TABLE 14 LIVE CELL IMAGING STANDALONE SYSTEMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
       TABLE 15 LIVE CELL IMAGING STANDALONE SYSTEMS MARKET, BY REGION, 2018-2025 (UNITS)
           7.3.3 CELL ANALYZERS
                    7.3.3.1 Players offer a wide range of cell analyzers to satisfy end-user demands
       TABLE 16 CELL ANALYZERS OFFERED BY KEY MARKET PLAYERS
       TABLE 17 LIVE CELL IMAGING CELL ANALYZERS MARKET, BY COUNTRY,2018-2025 (USD MILLION)
           7.3.4 ACCESSORIES
                    7.3.4.1 Accessories find wide use in live cell image analysis
       TABLE 18 ACCESSORIES OFFERED BY KEY MARKET PLAYERS
       TABLE 19 LIVE CELL IMAGING ACCESSORIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    7.4 CONSUMABLES
 TABLE 20 LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
 TABLE 21 LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
           7.4.1 REAGENTS
                    7.4.1.1 Reagents have widespread usage in life sciences due to their application in various research activities
       TABLE 22 REAGENTS OFFERED BY KEY MARKET PLAYERS
       TABLE 23 LIVE CELL IMAGING REAGENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
           7.4.2 ASSAY KITS
                    7.4.2.1 Repeat purchase of assay kits-a key driver for market growth
       TABLE 24 ASSAY KITS OFFERED BY KEY MARKET PLAYERS
       TABLE 25 LIVE CELL IMAGING ASSAY KITS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
           7.4.3 MEDIA
                    7.4.3.1 Development of new and advanced technologies has resulted in an increased demand for high-quality media in biomedical research and processing
       TABLE 26 MEDIA OFFERED BY KEY MARKET PLAYERS
       TABLE 27 LIVE CELL IMAGING MEDIA MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
           7.4.4 OTHER CONSUMABLES
   TABLE 28 OTHER CONSUMABLES OFFERED BY KEY MARKET PLAYERS
   TABLE 29 OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    7.5 SOFTWARE
           7.5.1 TECHNOLOGICAL ADVANCEMENTS IN IMAGE ACQUISITION-A KEY DRIVER FOR MARKET GROWTH
   TABLE 30 SOFTWARE OFFERED BY KEY MARKET PLAYERS
   TABLE 31 LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    7.6 SERVICES
           7.6.1 AVAILABILITY OF A WIDE RANGE OF SERVICES AND GROWING NUMBER OF INITIATIVES BY KEY PLAYERS TO DRIVE THE SERVICES MARKET
   TABLE 32 SERVICES OFFERED BY KEY MARKET PLAYERS
   TABLE 33 LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)

8 LIVE CELL IMAGING MARKET, BY APPLICATION (Page No. - 91)
    8.1 INTRODUCTION
 TABLE 34 LIVE CELL IMAGING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    8.2 IMPACT OF COVID-19 ON THE LIVE CELL IMAGING APPLICATIONS MARKET
    8.3 CELL BIOLOGY
           8.3.1 INCREASING PREVALENCE OF CANCER TO DRIVE GROWTH IN THE CELL BIOLOGY APPLICATION SEGMENT
   TABLE 35 LIVE CELL IMAGING MARKET FOR CELL BIOLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
    8.4 STEM CELLS
           8.4.1 IMPORTANCE OF STEM CELL RESEARCH HAS BOOSTED INVESTMENTS IN THIS AREA
   TABLE 36 LIVE CELL IMAGING MARKET FOR STEM CELLS, BY COUNTRY, 2018-2025 (USD MILLION)
    8.5 DEVELOPMENTAL BIOLOGY
           8.5.1 GROWING RESEARCH IN DEVELOPMENTAL BIOLOGY-A KEY DRIVER FOR MARKET GROWTH
   TABLE 37 LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
    8.6 DRUG DISCOVERY
           8.6.1 USE OF HCS CELL-BASED ASSAYS HAS GROWN IN DRUG DEVELOPMENT STUDIES
   TABLE 38 LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2018-2025 (USD MILLION)

9 LIVE CELL IMAGING MARKET, BY TECHNOLOGY (Page No. - 97)
    9.1 INTRODUCTION
 TABLE 39 LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    9.2 TIME-LAPSE MICROSCOPY
           9.2.1 GROWING NUMBER OF CELL-BASED RESEARCH ACTIVITIES WILL DRIVE THE DEMAND FOR TIME-LAPSE MICROSCOPY
   TABLE 40 LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2018-2025 (USD MILLION)
    9.3 FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET)
           9.3.1 GROWING ADVANCEMENTS IN FLUORESCENT MATERIALS AND PROBES WILL INCREASE THE ADOPTION OF FRET TECHNOLOGY
   TABLE 41 LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2018-2025 (USD MILLION)
    9.4 FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING (FRAP)
           9.4.1 ADVANCEMENTS IN CONFOCAL MICROSCOPY WILL SUPPORT THE MARKET GROWTH FOR FRAP
   TABLE 42 LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2018-2025 (USD MILLION)
    9.5 HIGH-CONTENT SCREENING (HCS)
           9.5.1 INCREASING DRUG DISCOVERY RESEARCH TO DRIVE THE GROWTH OF THIS MARKET
   TABLE 43 LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2018-2025 (USD MILLION)
    9.6 OTHER TECHNOLOGIES
 TABLE 44 LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2018-2025 (USD MILLION)

10 LIVE CELL IMAGING MARKET, BY END USER (Page No. - 104)
    10.1 INTRODUCTION
  TABLE 45 LIVE CELL IMAGING MARKET, BY END USER, 2018-2025 (USD MILLION)
    10.2 IMPACT OF COVID-19 ON THE LIVE CELL IMAGING END-USER MARKET
    10.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
           10.3.1 INCREASING R&D ACTIVITIES AND THE PATENT CLIFF OF VARIOUS BLOCKBUSTER DRUGS TO INCREASE THE DEMAND FOR LIVE CELL IMAGING PRODUCTS AMONG PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    TABLE 46 LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION)
    10.4 ACADEMIC & RESEARCH INSTITUTES
           10.4.1 RISING FOCUS OF THESE END USERS ON STRENGTHENING THEIR OWN DRUG DISCOVERY RESEARCH PROGRAMS TO DRIVE MARKET GROWTH
    TABLE 47 LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2025 (USD MILLION)
    10.5 CONTRACT RESEARCH ORGANIZATIONS
           10.5.1 GROWING OUTSOURCING OF R&D ACTIVITIES BY PHARMACEUTICAL COMPANIES TO DRIVE THE DEMAND FOR LIVE CELL IMAGING SYSTEMS AMONG CONTRACT RESEARCH ORGANIZATIONS
    TABLE 48 LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2025 (USD MILLION)

11 LIVE CELL IMAGING MARKET, BY REGION (Page No. - 109)
    11.1 INTRODUCTION
    11.2 COVID-19 IMPACT ON THE LIVE CELL IMAGING MARKET
  TABLE 49 LIVE CELL IMAGING MARKET, BY REGION, 2018-2025 (USD MILLION)
    11.3 NORTH AMERICA
  FIGURE 25 NORTH AMERICA: LIVE CELL IMAGING MARKET SNAPSHOT
  TABLE 50 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  TABLE 51 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  TABLE 52 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  TABLE 53 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  TABLE 54 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  TABLE 55 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  TABLE 56 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY END USER, 2018-2025 (USD MILLION)
           11.3.1 US
                    11.3.1.1 The US dominates the North American live cell imaging market primarily due to the strong trend of pharmaceutical & biotechnology research and the high burden of cancer
        TABLE 57 US: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
        TABLE 58 US: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 59 US: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 60 US: LIVE CELL IMAGING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
        TABLE 61 US: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
        TABLE 62 US: LIVE CELL IMAGING MARKET, BY END USER, 2018-2025 (USD MILLION)
           11.3.2 CANADA
                    11.3.2.1 Government initiatives to promote research and the need to combat cancer are the key factors driving the growth of the live cell imaging market in Canada
        TABLE 63 CANADA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
        TABLE 64 CANADA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 65 CANADA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 66 CANADA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
        TABLE 67 CANADA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
        TABLE 68 CANADA: LIVE CELL IMAGING MARKET, BY END USER,2018-2025 (USD MILLION)
    11.4 EUROPE
  TABLE 69 EUROPE: LIVE CELL IMAGING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  TABLE 70 EUROPE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  TABLE 71 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  TABLE 72 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  TABLE 73 EUROPE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  TABLE 74 EUROPE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  TABLE 75 EUROPE: LIVE CELL IMAGING MARKET, BY END USER, 2018-2025 (USD MILLION)
           11.4.1 GERMANY
                    11.4.1.1 Presence of a large number of academic research institutes and increasing R&D spending to drive the demand for live cell imaging in Germany
        TABLE 76 GERMANY: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
        TABLE 77 GERMANY: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 78 GERMANY: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 79 GERMANY: LIVE CELL IMAGING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
        TABLE 80 GERMANY: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
        TABLE 81 GERMANY: LIVE CELL IMAGING MARKET, BY END USER, 2018-2025 (USD MILLION)
           11.4.2 UK
                    11.4.2.1 High prevalence of cancer to drive market growth in the UK
        TABLE 82 UK: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
        TABLE 83 UK: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 84 UK: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 85 UK: LIVE CELL IMAGING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
        TABLE 86 UK: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
        TABLE 87 UK: LIVE CELL IMAGING MARKET, BY END USER, 2018-2025 (USD MILLION)
           11.4.3 FRANCE
                    11.4.3.1 Growth in the live cell imaging market in France can be attributed to the large pharmaceutical manufacturing industry and the high public expenditure on R&D
        TABLE 88 FRANCE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
        TABLE 89 FRANCE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 90 FRANCE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 91 FRANCE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
        TABLE 92 FRANCE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
        TABLE 93 FRANCE: LIVE CELL IMAGING MARKET, BY END USER, 2018-2025 (USD MILLION)
           11.4.4 REST OF EUROPE (ROE)
    TABLE 94 ROE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    TABLE 95 ROE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    TABLE 96 ROE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    TABLE 97 ROE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    TABLE 98 ROE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    TABLE 99 ROE: LIVE CELL IMAGING MARKET, BY END USER, 2018-2025 (USD MILLION)
    11.5 ASIA PACIFIC
  FIGURE 26 ASIA PACIFIC: LIVE CELL IMAGING MARKET SNAPSHOT
  TABLE 100 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  TABLE 101 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  TABLE 102 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  TABLE 103 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  TABLE 104 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  TABLE 105 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  TABLE 106 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY END USER, 2018-2025 (USD MILLION)
           11.5.1 CHINA
                    11.5.1.1 China to register the highest growth rate in the Asia Pacific live cell imaging market during the forecast period
        TABLE 107 CHINA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
        TABLE 108 CHINA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 109 CHINA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 110 CHINA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
        TABLE 111 CHINA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
        TABLE 112 CHINA: LIVE CELL IMAGING MARKET, BY END USER, 2018-2025 (USD MILLION)
           11.5.2 JAPAN
                    11.5.2.1 Rising prominence of regenerative medicine research and an increasing number of researchers to support market growth in Japan
        TABLE 113 JAPAN: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
        TABLE 114 JAPAN: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 115 JAPAN: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 116 JAPAN: LIVE CELL IMAGING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
        TABLE 117 JAPAN: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
        TABLE 118 JAPAN: LIVE CELL IMAGING MARKET, BY END USER, 2018-2025 (USD MILLION)
           11.5.3 INDIA
                    11.5.3.1 Favorable changes in foreign direct investment (FDI) regulations in the pharmaceutical industry to drive market growth in India
        TABLE 119 INDIA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
        TABLE 120 INDIA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 121 INDIA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 122 INDIA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
        TABLE 123 INDIA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
        TABLE 124 INDIA: LIVE CELL IMAGING MARKET, BY END USER, 2018-2025 (USD MILLION)
           11.5.4 REST OF ASIA PACIFIC (ROAPAC)
    TABLE 125 ROAPAC: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    TABLE 126 ROAPAC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    TABLE 127 ROAPAC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    TABLE 128 ROAPAC: LIVE CELL IMAGING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    TABLE 129 ROAPAC: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    TABLE 130 ROAPAC: LIVE CELL IMAGING MARKET, BY END USER, 2018-2025 (USD MILLION)
    11.6 LATIN AMERICA
           11.6.1 MAJOR PLAYERS ESTABLISHING MANUFACTURING FACILITIES IN LATIN AMERICA TO LEVERAGE THE LOW LABOR COST-A KEY GROWTH DRIVER
    TABLE 131 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    TABLE 132 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    TABLE 133 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    TABLE 134 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    TABLE 135 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    TABLE 136 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY END USER, 2018-2025 (USD MILLION)
    11.7 MIDDLE EAST & AFRICA
           11.7.1 SHORTAGE OF TRAINED PROFESSIONALS TO RESTRAIN THE GROWTH OF THE CELL ANALYSIS MARKET IN THE MIDDLE EAST & AFRICA
    TABLE 137 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    TABLE 138 MIDDLE EAST & AFRICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    TABLE 139 MIDDLE EAST & AFRICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    TABLE 140 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    TABLE 141 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    TABLE 142 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY END USER, 2018-2025 (USD MILLION)

12 COMPETITIVE LANDSCAPE (Page No. - 159)
    12.1 OVERVIEW
  FIGURE 27 KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS FROM JANUARY 2018 TO SEPTEMBER 2020
    12.2 COMPETITIVE SITUATION AND TRENDS
           12.2.1 PRODUCT LAUNCHES
    TABLE 143 PRODUCT LAUNCHES
           12.2.2 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
    TABLE 144 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
           12.2.3 ACQUISITIONS
    TABLE 145 ACQUISITIONS
           12.2.4 EXPANSIONS
    TABLE 146 KEY EXPANSIONS

13 COMPANY EVALUATION MATRIX AND COMPANY PROFILES (Page No. - 163)
    13.1 COMPANY EVALUATION MATRIX DEFINITION & METHODOLOGY
    13.2 COMPETITIVE LEADERSHIP MAPPING
           13.2.1 STARS
           13.2.2 EMERGING LEADERS
           13.2.3 PERVASIVE COMPANIES
           13.2.4 EMERGING COMPANIES
    FIGURE 28 LIVE CELL IMAGING MARKET: COMPETITIVE LEADERSHIP MAPPING (2019)
    13.3 MARKET SHARE ANALYSIS
  FIGURE 29 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019
    13.4 COMPANY PROFILES
  (Business Overview, Products Offered, Recent Developments, MnM View)*
           13.4.1 DANAHER CORPORATION
    FIGURE 30 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
           13.4.2 CARL ZEISS AG
    FIGURE 31 CARL ZEISS AG: COMPANY SNAPSHOT (2019)
           13.4.3 NIKON CORPORATION
    FIGURE 32 NIKON CORPORATION: COMPANY SNAPSHOT (2019)
           13.4.4 OLYMPUS CORPORATION
    FIGURE 33 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2019)
           13.4.5 PERKINELMER INC.
    FIGURE 34 PERKINELMER INC.: COMPANY SNAPSHOT (2019)
           13.4.6 SARTORIUS AG
    FIGURE 35 SARTORIUS AG: COMPANY SNAPSHOT (2019)
           13.4.7 BIOTEK INSTRUMENTS, INC.
           13.4.8 THERMO FISHER SCIENTIFIC
    FIGURE 36 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019)
           13.4.9 ETALUMA, INC.
           13.4.10 CYTOSMART TECHNOLOGIES
           13.4.11 NANOENTEK INC.
           13.4.12 GE HEALTHCARE
     FIGURE 37 GE HEALTHCARE: COMPANY SNAPSHOT (2019)
           13.4.13 BRUKER CORPORATION
     FIGURE 38 BRUKER CORPORATION: COMPANY SNAPSHOT (2019)
           13.4.14 BECTON, DICKINSON AND COMPANY
     FIGURE 39 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019)
           13.4.15 MERCK KGAA
     FIGURE 40 MERCK KGAA: COMPANY SNAPSHOT (2019)
           13.4.16 KEYENCE CORPORATION
           13.4.17 LOGOS BIOSYSTEMS (ALIGNED GENETICS INC.)
           13.4.18 NANOLIVE SA
           13.4.19 SONY BIOTECHNOLOGY INC.
           13.4.20 PHASE FOCUS LTD.
    

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
 
14 APPENDIX (Page No. - 204)
    14.1 INSIGHTS FROM INDUSTRY EXPERTS
    14.2 DISCUSSION GUIDE
    14.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    14.4 AVAILABLE CUSTOMIZATIONS
    14.5 RELATED REPORTS
    14.6 AUTHOR DETAILS

The study involved four major activities in estimating the size of the live cell imaging market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research. The bottom-up approach was employed to estimate the overall market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments. 

Secondary Research

In the secondary research process, various sources such Microscopy Society of America (MSA), European Microscopy Society (EMS), Australian Microscopy and Microanalysis Society (AMMS), American Society for Cell Biology (ASCB), World Health Organization (WHO), Organisation for Economic Co-operation and Development (OECD), and Centers for Disease Control and Prevention (CDC) among others, as well as the Annual Reports/SEC Filings, Investor Presentations of various companies, and the press releases of critical players (white papers; journals/magazines; and news articles) were considered. 

Primary Research

In the primary research process, industry experts from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Industry experts from the supply side include CEOs, vice presidents, marketing and sales directors, product managers, business development managers, technology and innovation directors of companies providing live cell imaging products, key opinion leaders, and suppliers and distributors. The industry experts from the demand side include academic researchers, cell culture specialists, and R&D professinals from pharmaceutical & biotechnology companies. 

Following the breakdown of primary respondents-

Live Cell Imaging Market Size

To know about the assumptions considered for the study, download the pdf brochure

Note 1: C-level primaries include CEOs, COOs, CTOs, VPs, and AVPs.

 2: Others include sales managers, marketing managers, and product managers.

 3: Tiers of the companies are defined according to their revenues. As of 2019: Tier 1 = >USD 1 billion, Tier 2 = USD 100 million to USD 1 billion, and Tier 3 =

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by product & service, by application, by technology, end user, and region). 

Bottom-up Approach

In this report, the global live cell imaging market size was arrived by obtaining revenues for individual companies through public sources and databases. Shares of leading players in the live cell imaging market were gathered from secondary sources to the extent available. In some instances, the shares of the live cell imaging  businesses have been ascertained after a detailed analysis of various parameters, including the product portfolio, market positioning, selling price, and geographic reach and strength, among others. Wherever feasible, revenue share analysis was also employed to arrive at segmental market sizes, by identifying leading players in respective product categories. 

Bottom-up Approach

Live Cell Imaging Market Bottom Up Approach

To know about the assumptions considered for the study, Request for Free Sample Report

Top-down Approach

Individual shares of each product segment were arrived at by assigning weightages based on their utilization/adoption rate. Regional splits of the overall live cell imaging market and its sub-segments are based on the adoption or utilization rates of the given products in respective regions or countries. For countries with limited availability of reliable and recent data, analogy/benchmarking-based market estimation and forecast technique was used. 

Data Triangulation

After arriving at the market size, the total live cell imaging market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.                                                        

Report Objectives

  • To define, describe, and forecast the global live cell imaging market by product, application, technology, end user, and region
  • To provide detailed information about the factors influencing the market growth (drivers, restraints, opportunities, and challenges)
  • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the live cell imaging market in five regions (along with major countries)—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.
  • To profile key players in the live cell imaging market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments such as acquisitions; new product/technology launches; collaborations, partnerships, and agreements; and expansions of the leading players in the global live cell imaging market 

Available customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report: 

Geographic Analysis

  • Further breakdown of the Rest of Asia Pacific live cell imaging market into Australia, South Korea, and other countries
  • Further breakdown of the Rest of Europe live cell imaging market into Italy, Spain, Russia, the Netherlands, Switzerland, and other countries

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)
COVID-19

Get in-depth analysis of the COVID-19 impact on the Live Cell Imaging Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Live Cell Imaging Market

Request For Special Pricing
Report Code
BT 3390
Published ON
Oct, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Live Cell Imaging Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved